Study Finds Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients Better Than Standard Care

[Thomson Reuters ONE] – MINNEAPOLIS – February 14, 2014 – Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF ( CRY ptogenic ST roke A nd under L ying A trial F ibrillation) Clinical Trial, which found that … more

View todays social media effects on MDT

View the latest stocks trending across Twitter. Click to view dashboard

See who Medtronic is hiring next, click here to view